In a setback for Novartis AG, the U.S. Food and Drug Administration asked the Swiss drug maker for more information about its meningitis-vaccine candidate, Menveo, with respect to patients between ages 11 and 55.
Links:
[1] http://admin.indiaenvironmentportal.org.in/news/novartis-vaccine-gets-scrutinized
[2] http://admin.indiaenvironmentportal.org.in/category/newspaper/asian-wall-street-journal-hong-kong
[3] http://admin.indiaenvironmentportal.org.in/category/thesaurus/drug-industry
[4] http://admin.indiaenvironmentportal.org.in/category/thesaurus/vaccination
[5] http://admin.indiaenvironmentportal.org.in/category/thesaurus/meningitis
[6] http://admin.indiaenvironmentportal.org.in/category/thesaurus/united-states-america-us